The improvements of the regulatory environment as well as the increase in foreign direct investment make Mexico\u2019s consumer healthcare and pharma market more attractive to multinational drug makers.<\/span><\/p>\n

<\/span><\/p>\n

Market Regulations<\/b><\/h3>\n

In recent years the market has been more strictly regulated, and new regulations were implemented.\u00a0<\/span><\/p>\n

A change of presidency brought to the signing of the agreement with the United Nations Office for Project Services \u2013 UNOPS, to entrust it with the management of the consolidated purchase of medicines and medical supplies for the period 2021-2024. The agreement covers the entire Consumer Healthcare sector, but there would be only one government institution \u2013 the National Institute of Health for Wellbeing (INSABI) able to coordinate the consolidated purchase of medicine together with UNOPS.<\/span><\/p>\n

It is necessary to mention that Mexico works the same way as European countries: Medicines are supplied to pharmacies by <\/span>2-3 major wholesalers<\/b>. Moreover, the role of wholesalers in the Mexican OTC and pharma market has been gradually reduced, and the wholesalers\u2019 functions are being taken over partly by the growing pharmacy chains.<\/span><\/p>\n

The Mexican pharmacy business attracts more and more foreign investors. And those who enter the Mexican consumer health and Rx Market with care and local knowledge will be the most successful players in one of the world\u2019s largest economies.<\/span><\/p>\n

<\/span><\/p>\n

<\/span><\/p>\n

Chameleon Pharma Consulting Group<\/b><\/h3>\n

has a long-standing network and has extensive experience based on many projects in Mexico. We operate in various global industry segments, such as Consumer Health Care, Medical Devices, Rx, OTC and Cosmetics. We are happy to help you with your international strategy and are here to assist you with Regulatory topics, GMP Certificates, and Market Entry.<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Expert Knowledge» _builder_version=»4.16″ _module_preset=»default» min_height=»609.2px» custom_margin=»-67px||-121px|||» custom_padding=»75px|||||» locked=»off» global_colors_info=»{}»][et_pb_row admin_label=»Row» _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» min_height=»45px» custom_padding=»||0px|||» global_colors_info=»{}»]<\/p>\n

The Mexican OTC and pharma market in 2035<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_2,1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_icon font_icon=»||divi||400″ icon_color=»#001389″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][\/et_pb_icon][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

USD 32,36 Billion<\/b><\/h3>\n

[\/et_pb_text][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

OTC and pharma market size, ex-factory<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_icon font_icon=»||divi||400″ icon_color=»#001389″ _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»][\/et_pb_icon][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n

8-10%<\/b><\/h3>\n

[\/et_pb_text][et_pb_text _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»]<\/p>\n

OTC and pharma market growth<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Number Counter» _builder_version=»4.16″ _module_preset=»default» background_color=»#EEEEEE» custom_margin=»-28px|||||» custom_padding=»7px||17px|||» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»]<\/p>\n

Mexico in numbers<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_3,1_3,1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Total population » number=»130 207 371 » percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» number_font_size=»65px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Male\/Female » number=»0.96″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Population growth » number=»1.04%» percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_3,1_3,1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Birth rate » number=»17.29\/1000″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» number_font_size=»72px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Mortality rate » number=»5.41\/1000″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Life expectancy» number=»76.94 years» percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_cta title=»Interested in this market?» button_url=»https:\/\/www.chameleon-pharma.com\/about\/contacts\/» button_text=»Click Here» _builder_version=»4.16″ _module_preset=»default» background_color=»#0B0B7A» global_colors_info=»{}»]<\/p>\n

\n

\n

<\/span><\/p>\n

We are ready to support you in\u00a0<\/span>Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory\u00a0projects,<\/span>\u00a0and more in order to ensure your growth.<\/span><\/p>\n<\/div>\n<\/div>\n

[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

MexicoFeatured image: Photo by Robbie Herrera on UnsplashMexico: the huge potential of its Consumer Healthcare and Rx market\u00a0 Mexico is one of the most attractive Emerging Markets in the world. Geographically, it lies in Latin America, which contains numerous Emerging Markets. Yet this one is so significant that Mexican Consumer Healthcare and Rx industry deserves […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8782,"menu_order":65,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[caption id=\"attachment_1928\" align=\"alignleft\" width=\"431\"] Ciudad de M\u00e9xico <\/a>by Aloud..<\/a>[\/caption]\r\n\r\nDuring the last couple of years, Mexico has grown to be one of the leading producers of pharmaceutical products in the Americas as well as the main exporter of pharmaceutical products to Europe and the USA in Latin America.\r\n\r\nThe Mexican pharmaceutical market is the second largest Latin American market after Brazil and it accounts for 1.5% of the country\u2019s GDP. In 2013, the Mexican healthcare market accounted for 17.6 billion USD, although the market\u2019s sales slowed in 2012-2013. However, experts predict an annual market growth rate of 6.8% until the Mexican pharmaceutical market will be worth approximately 22.5 billion USD in 2020.\r\n\r\nThese high growth rates are mainly attributable to an aging population, a growing middle class, a stale business environment as well as an improved access to health care services that increases the consumer\u2019s demand for pharmaceutical products. Moreover, the government is currently transforming the national health care model to focus on disease prevention due to a noticeable epidemiological transition from communicable to chronic degenerative diseases in Mexico.\r\n\r\nMexico also has one of the largest penetrations of generic products worldwide with 84%, and the generics market is expected to grow further by 12.6% annually during the next couple of years. This estimated growth is mainly due to the expiry of several drug patents as well as the implementation of new laws on bioequivalence. Additionally, the Mexican government further promotes the introduction of generic products at affordable prices to the Mexican pharmaceutical market by both foreign and domestic companies.","_et_gb_content_width":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8855","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/comments?post=8855"}],"version-history":[{"count":11,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8855\/revisions"}],"predecessor-version":[{"id":17487,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8855\/revisions\/17487"}],"up":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/media?parent=8855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}